Konferenzen  >  Medizin & Gesundheitswesen  >  Translationale Medizin, Klinische Studien

FDAMap

Are you ready to elevate your clinical trial process with the power of smart trials? This one-day virtual program is your gateway to transforming how trials are conducted. Imagine cutting timelines, slashing costs, and driving incredible ROI with advanced virtual tools, data-driven methodologies, and streamlined operations! This program will take you from traditional trial challenges to a smart, virtual-first strategy that amplifies results and redefines success.

FDA, Smart Clinical Trials, Clinical Trials, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Pharmakologie und Arzneimittelentwicklung

FDAMap

Clinical trials are highly regulated multi-dimensional projects that require constant interactions between the regulators and the sponsors, investigators, other personnel, and even patients involved in the conduct of a given trial. There are many diverse tasks involved in the conduct of a clinical trial starting from the development of a clinical trial protocol, finding and starting clinical trial sites, filing of an IND or IDE application, approvals from IRBs, numerous documents need to be collected to demonstrate compliance with regulations; managing supplies, collecting data, writing reports, and many other things. Clinical project managers need to understand, implement, and trouble-shoot practically all aspects of the clinical trial under them. Clinical project managers have to build teams and have clear perspective of what may be needed for assuring compliance with FDA requirements of a given clinical trial at all times. This one-of-a-kind program will train you in regulatory affairs, clinical operations, monitoring, patient recruitment and retention, planning, medical writing, safety monitoring and practically all major aspects of running a clinical trial.

FDA, Clinical Project Management, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Pharmakologie und Arzneimittelentwicklung

FDAMap

SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. They are frequently poorly written, communicated, monitored and enforced. This workshop will provide step by step instructions to create SOPs for FDA-regulated organizations.

FDA, SOPs, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Pharmakologie und Arzneimittelentwicklung

FDAMap

In the field of regulatory affairs, professionals often encounter the task of writing complex documents for diverse audiences. These documents encompass a wide range, including reports, protocols, clinical trial and marketing approval applications, technical reports on studies, and various communication documents. The purpose of this exclusive technical writing workshop is to provide regulatory professionals with valuable insights into best practices and regulatory strategies for crafting effective documents. The workshop will cover a spectrum of writing needs, from simple issues like minutes of meetings and correspondence notes to more intricate tasks such as producing comprehensive nonclinical and clinical study reports, as well as regulatory submissions to regulatory bodies such as FDA, EMA, Health Canada, and others.

FDA, ​Technical Writing, Regulatory Writing, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Pharmakologie und Arzneimittelentwicklung

European Association for the Study of the Liver (EASL)

The need to understand basic epidemiological concepts cannot be overstated for researchers wanting to make a career in any medical field, including hepatology. This course will give an overview of common and cutting-edge methodologies in clinical epidemiology that will be highly useful for clinicians wanting to develop their capacity to read, interpret, and understand limitations of clinical studies in medical journals. Instead of presenting a clinical case, the course will focus on practical skills needed to understand or design clinical studies and to be able to spot flaws and limitations in their own and other’s research work. In essence, this course will improve the knowledge of applied clinical study design and methodology for the next generation of clinicians and clinical researchers in hepatology.

Hepatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Kenes Exhibitions

Join us for the 3rd RNA Horizons Conference, taking place September 16–18, 2026, in Munich, Germany. This premier event brings together scientists, clinicians, and biotech innovators to explore the latest advancements in RNA therapeutics, spanning established modalities as well as emerging areas such as ASOs and RNA structure–based therapies. Discussions will cover key trends, including pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will focus on translating discoveries into viable therapies, with insights into commercialization and market access.

Tel.: [972 747457435];     Email: skrein@kenes-exhibitions.com

RNA therapeutics, RNA biology, RNA medicine, RNA delivery, antisense oligonucleotides, self-amplifying RNA, RNA-based therapy, cancer research, oncology innovation, RNA stability, clinical translation, biotechnology, life sciences, European biotech, Horizon Europe, CANCERNA consortium, Hadassah Cancer Research Institute, RNA Horizons, RNA conference Europe, Munich 2026, RNA innovation, European research collaboration

Biotechnologie,    Pharmakologie und Arzneimittelentwicklung